Plant Genomics Market - Global Forecast 2025-2032

Plant genomics is rapidly advancing as a foundational force in agricultural and biotech innovation, addressing global priorities in sustainable food production, crop resilience, and advanced genetic research. Senior leaders are exploring this dynamic landscape to adapt strategy, enhance supply chain resilience, and accelerate technology adoption.

Market Snapshot: Plant Genomics Market Size, Growth, and Opportunities

The Plant Genomics Market grew from USD 11.16 billion in 2024 to USD 12.23 billion in 2025 and is projected to expand at a CAGR of 9.50%, reaching USD 23.09 billion by 2032. This growth reflects rising demand for advanced genomic solutions to meet the increasing complexity of global food security, the adoption of precision agriculture, and the convergence of gene editing and sequencing technologies. Key players are intensifying investments, while new entrants and regulatory shifts drive adaptation within supply chains and global procurement strategies.

Scope & Segmentation

This report delivers comprehensive analysis and projections across the full spectrum of plant genomics, examining developments in product types, technology platforms, service models, use cases, and market reach. Major segmentation highlights include:

• Product Types: Instruments, reagents & consumables, services, software
• Technologies: Gene editing (Crispr, transcription activator-like effector nucleases, zinc finger nucleases), polymerase chain reaction (digital, quantitative, and reverse transcription), sequencing (next-generation, Sanger, third-generation)
• Service Models: Consulting, contract research, data analysis
• Applications: Agriculture (disease resistance, genetic improvement, yield optimization), diagnostics (genetic and infectious disease testing, prenatal testing), research (basic, biomarker, and drug discovery)
• End Users: Academic and research institutes, agriculture firms, hospitals & diagnostic labs, pharmaceutical & biotechnology companies
• Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe/Middle East/Africa (UK, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, UAE, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan)
• Companies Featured: Illumina, Thermo Fisher Scientific, BGI Genomics, QIAGEN, Agilent Technologies, PerkinElmer, Pacific Biosciences, Oxford Nanopore Technologies, Eurofins Scientific, Merck KGaA

Key Takeaways for Senior Decision-Makers

• Rapid commercial adoption of high-throughput sequencing and advanced gene editing is transforming crop development and agricultural value chains.
• The integration of AI and machine learning into genomics workflows is enabling smarter trait selection and predictive breeding, increasing competitive differentiation for early movers.
• Strategic partnerships between technology providers, public-sector institutions, and private enterprises are catalyzing open knowledge exchange and shared data resource creation.
• Complex regulatory frameworks and evolving compliance expectations require active stakeholder alignment, especially across EMEA and Asia-Pacific regions.
• Service and software segments display strong traction among research institutes and industry laboratories, given the growing need for informatics and contract research support.
• Emerging markets in Asia-Pacific and selected parts of EMEA are investing in local capacity, creating new entry points for tailored solutions addressing climate resilience and food security.

Tariff Impact: Navigating Regulatory and Supply Chain Disruptions

The imposition of new United States tariffs in 2025 has increased operational costs and prolonged procurement cycles for many sectors relying on specialized reagents, instruments, and software. Procurement leaders are now focusing on diversified sourcing strategies and localizing critical input manufacturing. These measures are intended to bolster research continuity and reduce the risks posed by cross-border trade disruptions. Collaboration with domestic and regional suppliers is becoming a core resilience strategy for research and production operations.

Methodology & Data Sources

This analysis leverages an integrated approach, combining primary interviews with sector experts, R&D leadership, procurement managers, and policy advisers, alongside comprehensive secondary research. Validation includes peer-reviewed literature, industry white papers, patent and regulatory filings, and company disclosures. The study ensures methodological rigor through data triangulation, validation workshops, and expert panel reviews.

Why This Report Matters

• Gain strategic insights for investment, partnership, and product development decisions aligned with major market shifts.
• Equip leadership teams with actionable segment, regional, and technology-level intelligence to inform agile growth strategies.

The report enables decision-makers to navigate uncertainty, respond to tariff impacts, and unlock opportunities in rapidly evolving global plant genomics ecosystems.

Conclusion

The plant genomics sector is entering a decisive phase driven by innovation, regulatory shifts, and global collaboration. Senior executives equipped with these insights can confidently plan for resilient growth and sustainable transformation within their organizations.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.